Related Experiment Video

Updated: May 18, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

Long-term clinical experience with zofenopril

Claudio Borghi1, Stefano Bacchelli, Daniela Degli Esposti

  • 1Unità Operativa di Medicina Interna, Policlinico S. Orsola-Malpighi, University of Bologna, Via Albertoni 15-40138, Bologna, Italy. claudio.borghi@unibo.it

Expert Review of Cardiovascular Therapy
|October 4, 2012
PubMed

Insights

Zofenopril effectively treats cardiovascular diseases, including myocardial infarction, by improving blood pressure and cardiac function. Clinical trials show zofenopril reduces mortality and morbidity, offering significant cardiovascular protection.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Angiotensin-converting enzyme (ACE) inhibitors are crucial for managing cardiovascular diseases.
  • Zofenopril demonstrates efficacy in improving blood pressure, left ventricular function, and myocardial ischemia.
  • ACE inhibition is a key mechanism for cardiovascular protection.

Purpose of the Study:

  • To evaluate the effectiveness of zofenopril in patients with coronary artery disease and myocardial infarction.
  • To assess the impact of zofenopril on mortality, morbidity, and ischemic burden.
  • To compare zofenopril with other ACE inhibitors like lisinopril and ramipril.

Main Methods:

  • The SMILE project involved over 3500 patients with coronary artery disease.
  • Studies assessed clinical outcomes, including mortality and morbidity, in myocardial infarction patients.
  • The SMILE-ISCHEMIA study specifically investigated the anti-ischemic effects of zofenopril.

Main Results:

  • Zofenopril treatment, especially with acetyl salicylic acid, reduced mortality and morbidity in myocardial infarction patients.
  • Zofenopril demonstrated superior outcomes compared to lisinopril and ramipril in certain patient groups.
  • Zofenopril exhibited a notable anti-ischemic effect, contributing to its overall clinical benefit.

Conclusions:

  • Zofenopril is highly effective in managing cardiovascular diseases, particularly coronary artery disease and myocardial infarction.
  • Its benefits include improved blood pressure control, enhanced left ventricular function, and reduced ischemia.
  • Zofenopril plays a primary role in the prevention and treatment of cardiovascular diseases, offering significant protection.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship01:14

Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship

For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...